Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

PROPOSED ADOPTION OF THE FIFTH AMENDED AND RESTATED ARTICLES OF ASSOCIATION 2023-03-31
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 2023-03-31
DATE OF BOARD MEETING 2023-03-16
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE IA/IB CLINICAL TRIAL OF JSKN003 IN CHINA FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS 2023-03-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 2023-03-06
Next Day Disclosure Return 2023-02-09
COMPLETION OF PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE 2023-02-09
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 2023-02-06
PLACING OF EXISTING SHARES AND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE 2023-02-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 2023-01-05

8 9 10 11 12 13 14